UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

 

For the month of October 2022

 

Commission File Number: 001-39365

 

Amryt Pharma plc
(Translation of registrant's name into English)

 

Dept 920a 196 High Road, Wood Green,
London, United Kingdom, N22 8HH
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [ X ]      Form 40-F [   ]

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):        

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):        

 

 

Exhibits

 

The following documents, which are attached as exhibits hereto, are incorporated by reference herein.

 

Exhibit   Title  
       
99.1   Press Release distributed October 17, 2022    
99.2   Press Release distributed October 18, 2022    
99.3   Press Release distributed October 19, 2022    
99.4   Press Release distributed October 24, 2022    
99.5   Press Release distributed October 25, 2022    
99.6   Press Release distributed October 31, 2022    
99.7   Press Release distributed November 3, 2022    

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

        Amryt Pharma plc    
    (Registrant)
     
     
Date: November 3, 2022       /s/ Rory Nealon    
    Rory Nealon
    Chief Financial Officer
     

 

Amryt Pharma (NASDAQ:AMYT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Amryt Pharma Charts.
Amryt Pharma (NASDAQ:AMYT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Amryt Pharma Charts.